Mehmet Cudi Tuncer

71PUBLICATIONS
49CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsRadiation therapyAutoimmunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (71)

|Sep 26, 2026
Correction: Maçin et al. Synergistic Anticancer Effects of Resveratrol and Carboplatin in Y79 Retinoblastoma Cells: Mechanistic Insights into Apoptosis, G2/M Arrest, and ROS-Dependent Mitochondrial Dysfunction. Int. J. Mol. Sci. 2026, 27, 3473.

|Sep 26, 2026
Epigallocatechin Gallate Modulates the Cellular Response to Doxorubicin in HeLa Cervical Cancer Cells.

|Sep 26, 2026
Cytotoxic, Drug-Interaction, and Apoptosis-Associated Effects of β-Boswellic Acid and Doxorubicin in Murine 4T1 TNBC-like Cells.

|Sep 26, 2026
Rosmarinic Acid Enhances Doxorubicin Activity in MDA-MB-231 Cells: Associations with Intracellular Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis.

|Aug 27, 2026
Thymoquinone Potentiates Docetaxel-Induced Antitumor Activity with the Involvement of ROS and PI3K/AKT Pathway Modulation in Triple-Negative Breast Cancer Cells.

|Aug 13, 2026
Rosmarinic Acid Sensitizes Ovarian Cancer Cells to Gemcitabine Through Oxidative Stress-Associated Apoptotic and Antiproliferative Responses.

Pageof 12

Frequent Collaborators

9 joint publications

İlhan Özdemir

5 joint publications

Şamil Öztürk

4 joint publications

Zülfikar Özgür Ertuğrul

4 joint publications

Mehmet Uğur Karabat